COL7A1 and pancreatic neoplasm: Medicherla et al. showed that SD-208, a small molecule inhibitor of TGF-β receptor I kinase, downregulates the expression of the TGF-β regulatory gene COL7A1 and improves intervention in the development of pancreatic cancer [33].